According to Stratistics MRC, the In- Vitro Fertilization (IVF)Market is estimated at $1.49 billion in 2015 and is projected to reach $5.66 billion by 2022 growing at a CAGR of 20.9% from 2015 to 2022. Increased occurrences of gamete donations, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures and rising incidence of infertility cases are some of the factors driving the market growth. Furthermore, availability of IVF treatments, increasing disposable income, favourable reimbursement policies, rising health awareness on fertility issues would further augment the market growth. However, high cost of devices, ethical considerations and multiple pregnancies are some of the restraints hampering the market growth. Recent innovations in IVF technology, such as Embryoscope and capsule IVF, are anticipated to boost the demand of IVF devices in future.

Micromanipulator is the highest revenue-generating segment owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment would witness a significant growth due to its extensive use in healthy sperm selection and gender determination. Europe and North America are expected to gain significant market share over the forecast period.